(Q41522732)

2 October 2017

title

Canine Leishmania vaccines: still a long way to go. (English)

1 reference

2 October 2017

1

Luigi Gradoni

1 reference

2 October 2017

publication date

15 January 2015

1 reference

2 October 2017

published in

Veterinary Parasitology

1 reference

2 October 2017

volume

208

1 reference

2 October 2017

issue

1-2

1 reference

2 October 2017

page(s)

94-100

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

2 October 2017

1 reference

Leishmaniasis worldwide and global estimates of its incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Role of sand fly saliva in human and experimental leishmaniasis: current insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Immunologic indicators of clinical progression during canine Leishmania infantum infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Vaccination with LiESP/QA-21 (CaniLeish®) reduces the intensity of infection in Phlebotomus perniciosus fed on Leishmania infantum infected dogs--a preliminary xenodiagnosis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Cytokine profiles in canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Risk factors for canine leishmaniasis in an endemic Mediterranean region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Heterogeneities in Leishmania infantum infection: using skin parasite burdens to identify highly infectious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Gentamicin-attenuated Leishmania infantum vaccine: protection of dogs against canine visceral leishmaniosis in endemic area of southeast of Iran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

The potential effects of global warming on changes in canine leishmaniasis in a focus outside the classical area of the disease in southern France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

The development and clinical evaluation of second-generation leishmaniasis vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Prospective study on the incidence and progression of clinical signs in naïve dogs naturally infected by Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Predicting the distribution of canine leishmaniasis in western Europe based on environmental variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

The current status of zoonotic leishmaniases and approaches to disease control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Immunity to visceral leishmaniasis: implications for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Methods for diagnosis of canine leishmaniasis and immune response to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Experimental transmission of Leishmania infantum by two major vectors: a comparison between a viscerotropic and a dermotropic strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Guidelines for prevention of leishmaniasis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Canine leishmaniosis--new concepts and insights on an expanding zoonosis: part two.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Development of Leishmania vaccines: predicting the future from past and present experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to two leishmania infantum transmission seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Prevention of canine leishmaniosis in a hyper-endemic area using a combination of 10% imidacloprid/4.5% flumethrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Vaccines for leishmaniasis in the fore coming 25 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Guidelines for diagnosis and clinical classification of leishmaniasis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Adjuvants for Leishmania vaccines: from models to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

The role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Cytokine expression during the outcome of canine experimental infection by Leishmania infantum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

High iNOS expression in macrophages in canine leishmaniasis is associated with low intracellular parasite burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2015.01.003

10.1016/J.VETPAR.2015.01.003

7 January 2021

Identifiers

DOI

1 reference

2 October 2017

1 reference